ReviewFrontiers in oncology2024

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.

Raffaele Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.